A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract - PubMed (original) (raw)

Review

A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract

Daniel Garrido et al. Adv Nutr. 2012.

Abstract

Bifidobacteria are commonly used as probiotics in dairy foods. Select bifidobacterial species are also early colonizers of the breast-fed infant colon; however, the mechanism for this enrichment is unclear. We previously showed that Bifidobacterium longum subsp. infantis is a prototypical bifidobacterial species that can readily utilize human milk oligosaccharides as the sole carbon source. MS-based glycoprofiling has revealed that numerous B. infantis strains preferentially consume small mass oligosaccharides, abundant in human milks. Genome sequencing revealed that B. infantis possesses a bias toward genes required to use mammalian-derived carbohydrates. Many of these genomic features encode enzymes that are active on milk oligosaccharides including a novel 40-kb region dedicated to oligosaccharide utilization. Biochemical and molecular characterization of the encoded glycosidases and transport proteins has further resolved the mechanism by which B. infantis selectively imports and catabolizes milk oligosaccharides. Expression studies indicate that many of these key functions are only induced during growth on milk oligosaccharides and not expressed during growth on other prebiotics. Analysis of numerous B. infantis isolates has confirmed that these genomic features are common among the B. infantis subspecies and likely constitute a competitive colonization strategy used by these unique bifidobacteria. By detailed characterization of the molecular mechanisms responsible, these studies provide a conceptual framework for bifidobacterial persistence and host interaction in the infant gastrointestinal tract mediated in part through consumption of human milk oligosaccharides.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: D. Garrido, D. Barile, and D.A. Mills, no conflicts of interest.

Figures

Figure 1

Figure 1

Possible strategies for human milk oligosaccharides (HMO) consumption in Bifidobacterium bifidum and Bifidobacterium infantis. Yellow circles indicate galactose; red triangles, fucose; blue squares, GlcNAc; purple diamonds, blue circles, glucose. Dashed lines in the HMO figure represent potential linkages. GNB, galacto-_N_-biose; LNB, lacto-_N_-biose.

Similar articles

Cited by

References

    1. German JB, Freeman SL, Lebrilla CB, Mills DA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program. 2008;62:205–18, discussion 18–22 - PMC - PubMed
    1. Cuthbertson WF. Evolution of infant nutrition. Br J Nutr. 1999;81:359–71 - PubMed
    1. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2002; (1):CD003517. - PubMed
    1. Fewtrell MS, Morgan JB, Duggan C, Gunnlaugsson G, Hibberd PL, Lucas A, Kleinman RE. Optimal duration of exclusive breastfeeding: what is the evidence to support current recommendations? Am J Clin Nutr. 2007;85:635S–8S - PubMed
    1. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr. 2010; 156(2, Suppl)S3–7 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources